Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 250
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Radiologe ; 58(10): 929-934, 2018 Oct.
Article in German | MEDLINE | ID: mdl-29992401

ABSTRACT

Intramammary manifestation of lymphoproliferative disease is rare. The radiological evaluation follows in most cases the clinical suspicion and therefore the radiologist takes an important place in diagnostics. The aim of this work is to demonstrate typical radiological patterns of this rare entity with multimodal cases and to sensitize for it. The differential diagnosis to other breast tumors, especially primary breast carcinoma, can be radiologically difficult, so the suspicious lesion must be histologically verified by biopsy.


Subject(s)
Breast Neoplasms , Mammography , Biopsy , Breast Neoplasms/diagnostic imaging , Diagnosis, Differential , Humans
2.
Radiologe ; 57(12): 1059-1070, 2017 Dec.
Article in German | MEDLINE | ID: mdl-29181716

ABSTRACT

There are many different tumors and tumor-like lesions with variable biological behavior that may affect the skeletal musculature. The aim of this study was to review the different intramuscular lesions and to provide aĀ classification based on their radiological patterns. Intramuscular lesions can present as solid, liquid, semiliquid or fat equivalent manifestations and also as diffuse muscle enlargement and muscle calcification. Additionally, lesions with mixed patterns of the aforementioned alterations can also occur. Benign and malignant muscle lesions can often manifest with identical radiological patterns, which is why a certain differentiation is often difficult. A systematic radiological description and when possible assignment with respect to etiology and dignity depending on the patient history is necessary in order to recommend a subsequent histological confirmation or to avoid unnecessary confirmation.


Subject(s)
Muscle Neoplasms/diagnostic imaging , Muscle, Skeletal/diagnostic imaging , Humans , Radiology
3.
Z Gastroenterol ; 52(8): 807-12, 2014 Aug.
Article in German | MEDLINE | ID: mdl-25111720

ABSTRACT

BACKGROUND: Following the introduction of the MELD score, the survival rates have worsened after liver transplantation (LTX) in Germany. Existing organ shortages, shorter survival rates after LTX, and failures in the liver allocation process provide true challenges. Facilitated by a structured questionnaire, the appropriate German liver transplantation actors were approached with regard to these challenges for the first time. The aim was to provide a balanced experts' view in an anonymous fashion thereby identifying areas for potential improvement. METHOD: Data collection was performed by a structured, standardised, anonymous survey of all LTX centres in Germany. RESULTS: We received 75Ć¢Ā€ĀŠ% replies of the questionnaires, 35 of 36 participants responded to more than 75Ć¢Ā€ĀŠ% of all questions. The following key points were highlighted. A minimum amount of LTX per centre was deemed important and monetary incentives must not exist. The ultimate goal of LTX is a prolongation of life and social as well as occupational reintegration. Quality management and transparent LTX registers are prerequisites for both adequate organ allocation and distribution of resources in order to achieve the best possible transplant outcomes. CONCLUSION: The German liver transplant experts consider transparency of organ allocation and systematic evaluation of the quality of transplant centres and the transplantation process itself to be mandatory, however, executed in a participatory way. A scoring system to facilitate the decision making process in order to predict the likelihood of satisfactory LTX outcome thereby circumventing some of the ethical and constitutional doubts would be highly appreciated.


Subject(s)
Access to Information/legislation & jurisprudence , Hospitals, Special/legislation & jurisprudence , Liver Failure/surgery , Liver Transplantation/legislation & jurisprudence , National Health Programs/legislation & jurisprudence , Postoperative Complications/mortality , Quality Assurance, Health Care/legislation & jurisprudence , Resource Allocation/legislation & jurisprudence , Germany , Humans , Liver Failure/mortality , Liver Function Tests , Liver Transplantation/mortality , Patient Selection , Surveys and Questionnaires , Survival Analysis , Tissue Donors/legislation & jurisprudence , Tissue Donors/supply & distribution , Truth Disclosure , Waiting Lists/mortality
4.
Rev Sci Instrum ; 95(9)2024 Sep 01.
Article in English | MEDLINE | ID: mdl-39248616

ABSTRACT

A rapid calibration system is under development for the Near Backscatter Imager (NBI) in use at the National Ignition Facility (NIF). NBI is an optical diagnostic that quantifies the stimulated Brillouin and Raman backscatter produced by NIF's targets. Specifically, NBI measures the light that does not fall directly back into the laser aperture, which is measured by the Full Aperture Backscatter System (FABS). When working in tandem with FABS, NBI allows for the full characterization of backscattered light. This informs Hohlraum laser coupling, optical damage, and laser-plasma interaction models. NBI uses a large Spectralon plate covered by a protective glass layer and is mounted inside the target chamber where it is exposed to high energy backscatter, neutrons, and build-up debris left over from the exploded targets. This gradually alters the reflectivity of the plate, meaning that NBI needs to be calibrated regularly. Described here is NIF's design for a system capable of rapid in situ calibration of NBI that is to be installed in FY25.

5.
Chirurgie (Heidelb) ; 94(3): 230-236, 2023 Mar.
Article in German | MEDLINE | ID: mdl-36786812

ABSTRACT

Inguinal hernia operations represent the most frequent operations overall with 300,000 interventions annually in Germany, Austria and Switzerland (DACH region). Despite the announced political willingness and the increasing pressure from the legislator to avoid costly inpatient treatment by carrying out as many outpatient operations as possible, outpatient treatment has so far played a subordinate role in the DACH region. The Boards of the specialist societies the German Hernia Society (DHG), the Surgical Working Group Hernia (CAH of the DHG), the Austrian Hernia Society (ƖHG) and the Swiss Working Group Hernia Surgery (SAHC) make inroads into this problem, describe the initial position and assess the current situation.


Subject(s)
Hernia, Inguinal , Humans , Hernia, Inguinal/surgery , Outpatients , Germany , Herniorrhaphy
6.
Unfallchirurg ; 115(1): 33-4, 2012 Jan.
Article in German | MEDLINE | ID: mdl-22274602

ABSTRACT

The German S3 Guideline on Treatment of Polytrauma/Severely Injured Patients characterizes key recommendations on the current diagnostic and therapeutic approach in concomitant thoracic and abdominal trauma based on the available scientific data. The special requirements for appropriate basic treatment can be derived for rural hospitals, even though the particular grade of recommendation often is low because evidence-based studies are still lacking.The options for adequate basic treatment of thoracic and abdominal trauma in patients with multiple injuries treated in rural hospitals substantially depend on the dedication, the level of experience and training, and the willingness of the locally responsible team to cooperate.


Subject(s)
Abdominal Injuries/surgery , Hospitals, Rural/standards , Multiple Trauma/surgery , Practice Guidelines as Topic , Professional Competence/standards , Thoracic Injuries/surgery , Traumatology/standards , Germany , Humans
7.
Pathologe ; 32 Suppl 2: 202-5, 2011 Nov.
Article in German | MEDLINE | ID: mdl-21837400

ABSTRACT

A variety of somatic genetic and epigenetic aberrations are discussed in the multistep carcinogenesis of tumors of the upper gastrointestinal tract but specific genetic changes are still unknown. Primary prevention of cancer is important and includes the control of causal endo- and exogenous factors. Screening endoscopies to detect premalignant lesions or early carcinoma cannot be recommended in the Western world. The incidence of preinvasive neoplasia, above all the high-grade intraepithelial neoplasia, in Barrett's esophagus or stomach is as low as 4.0 or 0.6%, respectively. Secondary prevention of cancer after changes of the mucosa should be performed by endoscopic diagnosis and treatment performing biopsies or resection of the lesion. After histological diagnosis of a high-grade intraepithelial neoplasia, complete resection of these lesions including complete ablation of Barrett's mucosa should be carried out. On the basis of an exact pathological report, close cooperation between endoscopist and surgeon seems to be necessary to find out the best individual therapy with curative intent.


Subject(s)
Adenocarcinoma/genetics , Adenocarcinoma/pathology , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Esophageal Neoplasms/genetics , Esophageal Neoplasms/pathology , Precancerous Conditions/genetics , Precancerous Conditions/pathology , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , Upper Gastrointestinal Tract/pathology , Adenocarcinoma/therapy , Biopsy , Carcinoma in Situ/genetics , Carcinoma in Situ/therapy , Carcinoma, Squamous Cell/therapy , Early Detection of Cancer , Endoscopy, Digestive System , Esophageal Neoplasms/therapy , Humans , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/prevention & control , Precancerous Conditions/therapy , Prognosis , Stomach Neoplasms/therapy , Watchful Waiting
8.
Zentralbl Chir ; 136(4): 317-24, 2011 Aug.
Article in German | MEDLINE | ID: mdl-21789757

ABSTRACT

BACKGROUND: The overall prognosis of gastric cancer with an overall 5-year survival of 25% is still poor despite improvements of the surgical and perioperative procedures. To improve the surgical treatment results other therapeutic options as chemo- and/or radiotherapy have been investigated for more than 20 years. METHODS: After a literature review, the results of actual trials of multimodality treatment were analysed and described. RESULTS: Adjuvant treatment was less effective compared with neoadjuvant or perioperative chemotherapy performed in advanced tumour categories T3/4. Actual trials could show that the rate of curative (R0) resection can be augmented resulting in an increase of the overall 5-year survival rate of more than 10 %. CONCLUSION: To confirm this trend, further studies with high pathological and surgical quality control are necessary as well as a more exact definition of prediction and evaluation of the response following chemotherapy.


Subject(s)
Stomach Neoplasms/therapy , Algorithms , Biopsy , Chemotherapy, Adjuvant , Combined Modality Therapy , Endoscopy, Digestive System , Gastrectomy , Humans , Lymph Node Excision , Neoadjuvant Therapy , Neoplasm Invasiveness , Neoplasm Staging , Pancreatectomy , Radiotherapy, Adjuvant , Randomized Controlled Trials as Topic , Splenectomy , Stomach Neoplasms/diagnosis , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Survival Rate
10.
Chirurg ; 91(1): 51-59, 2020 Jan.
Article in German | MEDLINE | ID: mdl-31654104

ABSTRACT

BACKGROUND: The digitalization process is currently on everyone's lips and sweeping changes in the field of public health and especially in surgery are to be expected within the next few years. Besides general issues, such as electronic health records and medical information systems, artificial intelligence, robotics and model-based surgery will decisively impact on the daily routine. In order to provide the necessary knowledge base, to point out related risks and chances and also to define fields of action for surgery, the German Society of Surgery commissioned a position paper on digitalization. AĀ first appraisal in form of an online survey is the subject of this article. METHODS: This article is based on an online survey of the members of the German Society of Surgery and selected members of other related societies. The survey asked for the members' personal assessment concerning different aspects of the digitalization process and the respective state of knowledge as well as the impact on the field of surgery. RESULTS: AĀ total of 296 members contributed to this survey. According to their assessment, digitalization in surgery is currently associated with terms such as electronic health records and medical information systems but they also assume a relevant influence on their own activities and on the fields of interventional medicine and surgery. AĀ relevant need for improvement of the current state of knowledge was highlighted, not only for general aspects of digitalization but also for surgically relevant issues in particular. The vast majority of interviewed members saw digitalization more as aĀ chance for improvement than as aĀ risk factor. CONCLUSION: According to the views of interviewed members of the German Society of Surgery the process of digital transformation will significantly impact the field of surgery. All those involved should feel responsible to contribute to and guide this process in order to maintain the surgically inherent requirements and to protect patient safety. The position paper on digitalization can serve as a basis and should define concrete recommendations for action. In the sense of an academic approach the new possibilities should be critically evaluated with respect to suitability and should be exclusively confined to applications that are beneficial to ourselves and to our patients.


Subject(s)
Artificial Intelligence , Electronic Health Records , General Surgery , Robotic Surgical Procedures , Attitude of Health Personnel , General Surgery/trends , Humans , Risk Factors , Surgeons , Surveys and Questionnaires
11.
Hernia ; 24(4): 747-757, 2020 08.
Article in English | MEDLINE | ID: mdl-31786700

ABSTRACT

INTRODUCTION: Inguinal hernias are repaired using either open or minimally invasive surgical techniques. For both types of surgery it has been demonstrated that a higher annual surgeon volume is associated with a lower risk of recurrence. This present study investigated the volume-outcome implications for recurrence operations, surgical complications, rate of chronic pain requiring treatment, and 30-day mortality based on the hospital volume. MATERIALS AND METHODS: The data basis used was the routine data collected throughout the Federal Republic of Germany for persons insured by the Local General Sickness Fund "AOK" who had undergone inpatient inguinal hernia repair between 2013 and 2015. Complications were recorded by means of indicators. Hospitals were divided into five groups on the basis of the annual caseload volume: 1-50, 51-75, 76-100, 101-125, and ≥ 126 inguinal hernia repairs per year. The effect of the hospital volume on the indicators was assessed using multiple logistic regression. RESULTS: 133,449 inguinal hernia repairs were included. The incidence for recurrence operations was 0.95%, for surgical complications 4.22%, for chronic pain requiring treatment 2.87%, and for the 30-day mortality 0.28%. Low volume hospitals (1-50 and 51-75 inguinal hernia repairs per year) showed a significantly increased recurrence risk compared to high volume hospitals with ≥ 126 inguinal hernia repairs per year (odds ratio: 1.53 and 1.24). No significant correlations were found for the other results. CONCLUSIONS: The study gives a detailed picture of hospital care for inguinal hernia repair in Germany. Furthermore, it was noted that the risk of hernia recurrence decreases in line with a rising caseload of the treating hospital.


Subject(s)
Hernia, Inguinal/surgery , Herniorrhaphy/statistics & numerical data , Hospitals, High-Volume/statistics & numerical data , Hospitals, Low-Volume/statistics & numerical data , Aged , Female , Germany , Humans , Male , Middle Aged , Recurrence , Surgeons , Treatment Outcome
12.
Zentralbl Chir ; 134(4): 362-74, 2009 Aug.
Article in German | MEDLINE | ID: mdl-19688686

ABSTRACT

AIM: This review comments on the diagnosis and treatment of gastric cancer in the classical meaning--excluding adenocarcinoma of the -oesophagogastric junction. Algorithms of diagnosis and care with respect to tumour stage are presented. PREOPERATIVE DIAGNOSIS: Besides oesophagogastroduodenoscopy, endoscopic ultrasonography is necessary for the accurate diagnosis of T categories and as a selection criterion for neoadjuvant chemotherapy. Computed tomography is recommended for preoperative evaluation of tumours > T1, laparoscopy has become an effective stag-ing tool in T3 and T4 tumours avoiding unnecessary laparotomies and improving the detection of small -liver and peritoneal metastases. TREATMENT: Endoscopic mucosal resection and submucosal dissection are indicated in superficial cancer confined to the mucosa with special characteristics (T1 a / no ulcer / G1, 2 / LaurƩn intestinal / L0 / V0 / tumour size < 2 cm). In all other cases total gastrectomy or distal subtotal gastric resection are indicated, the latter in cases of tumours located in the distal two-thirds of the stomach. Standard lymphadenectomy (LAD) is the D2 LAD without distal pancreatectomy and splenectomy. The Roux-en-Y oesophagojejunostomy is still the preferred type of reconstruction. An additional pouch reconstruction should be considered in -patients with favourable prognosis, this also -applies for the preservation of the duodenal passage by jejunum interposition. Extended organ resections are only indicated in cases where a R0-resection is possible. Hepatic resection for metachronous or synchronous liver metastases is rarely advised since 50 % of patients with liver metastases show concomitant peritoneal dissemination of the disease. DISCUSSION AND CONCLUSIONS: Undergoing gastrectomy at a high-volume centre is associated with lower in-hospital mortality and a better prognosis, however, clear thresholds for case load cannot be given. Perioperative chemotherapy and postoperative chemoradiotherapy are based on the MAGIC and MacDonald trials. Perioperative chemotherapy should be performed in patients with T3 and T4 tumours with the aim to increase the likelihood of curative R0-resection by downsizing the tumour. Adjuvant postoperative chemotherapy cannot be recommended since its benefit has so far not been proven in randomised trials. In selected patients with incomplete lymph-node dissection and questionable R0-resection postoperative chemoradiotherapy may be debated.


Subject(s)
Gastrectomy , Lymph Node Excision , Stomach Neoplasms/diagnosis , Stomach Neoplasms/surgery , Biopsy , Carcinoma in Situ/diagnosis , Carcinoma in Situ/pathology , Carcinoma in Situ/surgery , Disease-Free Survival , Gastric Mucosa/pathology , Gastric Mucosa/surgery , Gastroscopy , Humans , Laparoscopy , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Lymph Nodes/pathology , Neoplasm Invasiveness/pathology , Neoplasm Staging , Palliative Care , Perioperative Care , Peritoneal Lavage , Prognosis , Stomach/pathology , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology
13.
Chirurg ; 87(12): 1046-1053, 2016 Dec.
Article in German | MEDLINE | ID: mdl-27492377

ABSTRACT

Esophagectomy is considered to be aĀ high risk procedure regarding postoperative morbidity and mortality. Therefore, in Germany, these operations are limited to hospitals fulfilling aĀ minimum quantity. This systematic review focuses on risk and complication management regarding the impact of perioperative nutritional therapy, including the recent S3-guideline recommendations and comments of the German Working Group of Medical Societies (AWMF) which were established with contributions from the authors.


Subject(s)
Esophageal Neoplasms/surgery , Esophagectomy , Nutrition Therapy/methods , Perioperative Care , Postoperative Complications/prevention & control , Esophageal Neoplasms/pathology , Humans , Interdisciplinary Communication , Intersectoral Collaboration , Postoperative Complications/etiology , Practice Guidelines as Topic , Risk
14.
Chirurg ; 87(10): 865-72, 2016 Oct.
Article in German | MEDLINE | ID: mdl-27406251

ABSTRACT

The current German S3 guideline represents the recommendations for the diagnosis and therapy of squamous cell carcinomas and adenocarcinomas of the esophagus based on evidence from the literature and interdisciplinary expert consensus. Esophagogastroscopy with biopsy, endosonography, and spiral CT scan of the neck, thorax, and abdomen are decisive in staging and the choice of therapy. For aĀ curative approach, surgery, especially transthoracic esophagectomy and gastric pull-up, is the most important therapeutic option, except in the case of mucosal carcinomas or cervical squamous cell carcinomas. The significance of total minimally invasive esophageal resection or a hybrid technique is still uncertain. In category cT3 or resectable cT4 tumors, neoadjuvant radiochemotherapy should be performed in squamous cell carcinomas or adenocarcinomas. Alternatively, perioperative chemotherapy can be carried out in adenocarcinoma. Palliative resections should be avoided and replaced by interventional procedures for palliation.


Subject(s)
Adenocarcinoma/therapy , Carcinoma, Squamous Cell/therapy , Consensus , Esophageal Neoplasms/therapy , Evidence-Based Medicine , Guideline Adherence , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/pathology , Chemotherapy, Adjuvant , Diagnostic Imaging/methods , Endoscopy, Digestive System , Endosonography , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/pathology , Esophagectomy/methods , Humans , Lymph Node Excision/methods , Minimally Invasive Surgical Procedures/methods , Neoplasm Staging , Palliative Care/methods
15.
J Clin Oncol ; 7(9): 1310-7, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2671287

ABSTRACT

In this phase II multicenter trial, 67 evaluable patients with advanced measurable gastric carcinoma were treated with a combination of etoposide, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and cisplatin (EAP). The overall response rate was 64%, including 21% complete responses (CRs). In 55 patients with metastatic disease, 31 responses (51%) including eight CRs (15%) were achieved. Responses were seen in all metastatic sites, but the response rate was lower in patients with peritoneal carcinomatosis. In 12 patients with locoregional disease, six CRs and six partial responses (PRs) were observed. Eight CRs (three and five in patients with metastatic and locoregional disease, respectively) were pathologically confirmed. The overall median response duration was 7 months; it was 16 months for patients achieving CR (22 months for pathologically confirmed CR [pCR]), and 6 months for PR. The median survival time for all patients was 9 months, for the patients who achieved CR 17 months, for pCR 23 months, and for PR 9.5 months. Median survival time for all patients with metastatic disease was 8 months, and for locoregional disease 12.5 months. Six patients (9%) (four local, two metastatic disease) were alive at 2 years, and four patients are alive and disease free at 35+ to 56+ months. Main toxicities were leukopenia and thrombocytopenia, with 64% of patients developing grade 3 to 4 myelosuppression and 12% severe infections. Nonhematologic toxicities of World Health Organization (WHO) grade 4 were not observed.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Actuarial Analysis , Adult , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cisplatin/administration & dosage , Clinical Trials as Topic , Doxorubicin/administration & dosage , Drug Evaluation , Etoposide/administration & dosage , Female , Humans , Laparotomy , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Remission Induction , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology
16.
J Clin Oncol ; 7(9): 1318-26, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2769330

ABSTRACT

Thirty-four patients with locally advanced, nonresectable gastric cancer (staged by laparotomy) received etoposide, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and cisplatin (EAP). Thirty-three patients were evaluable for response and toxicity. Second-look surgery with removal of residual tumor by gastrectomy and lymphadenectomy was performed in case of complete/partial remission (CR/PR) after EAP. After successful resection (R0- and R1-resection), two cycles of EAP were administered for consolidation therapy. Patients refusing reoperation received up to six cycles of EAP. The response rate (CR/PR) after EAP was 70% (23/33), including a 21% (7/33) rate of clinical CRs (CCRs). Two patients had minor remission (MR)/no change and seven had progressive disease. There was one early death. Nineteen of 23 responders (5 CCRs, 14 clinical PRs [CPRs]) and one patient with MR underwent second-look surgery. Five CCRs were pathologically confirmed; 10 patients with CPR were without evidence of disease (NED) after resection. In three patients (CPR), R1-resections (microscopically tumor-cell positive proximal margin) were performed; two patients are disease-free, 22+ and 33+ months after consolidation chemotherapy. In two patients, the tumor was again considered nonresectable. Twenty patients were disease-free after EAP +/- surgery +/- consolidation chemotherapy. Toxicity was primarily hematologic. Leukopenia and thrombocytopenia of World Health Organization (WHO) grade 3 occurred in 30% and 9%, respectively and grade 4 in 18% and 9% of the patients, respectively. There was no increased peri- or postoperative morbidity. After a median follow-up of 20 months for disease-free patients, the relapse rate is 60% (12/20). The median survival time for all patients is 18 months and for disease-free patients 24 months. EAP is highly effective in locally advanced gastric cancer, and offers a chance for surgery with curative intention in patients with an otherwise fatal prognosis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gastrectomy , Stomach Neoplasms/drug therapy , Adult , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cisplatin/administration & dosage , Combined Modality Therapy , Doxorubicin/administration & dosage , Drug Evaluation , Etoposide/administration & dosage , Female , Humans , Laparotomy , Lymph Node Excision , Male , Middle Aged , Neoplasm Staging , Remission Induction , Reoperation , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery
18.
Eur J Surg Oncol ; 31(6): 595-604, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15919174

ABSTRACT

AIMS: The background was to analyse the influence of hospital- and surgeon volume and of the extent of resective procedures on the quality of early and late treatment results in gastric cancer. METHODS: The literature was reviewed by searching the databases of Medline, Cancerlit, Pubmed and the Cochran register. RESULTS: The levels of evidence showed wide variations. The influence of hospital volume was more important for the outcome than the case load of the individual surgeon. The extent of surgical resection should be adapted to histology--or stage. The value of systematic lymph node dissection is still under discussion. CONCLUSIONS: We have found that the best treatment results were seen in high volume hospitals with experienced surgeons, even taking into account extended surgical procedures. Further studies are needed to define the optimal number of operations necessary to be carried out each year.


Subject(s)
Gastrectomy/methods , Gastrectomy/statistics & numerical data , Gastrectomy/standards , Outcome Assessment, Health Care/methods , Quality of Health Care , Stomach Neoplasms/surgery , Surgery Department, Hospital/statistics & numerical data , Surgery Department, Hospital/standards , Clinical Trials as Topic , Germany/epidemiology , Hospital Mortality , Humans , Lymph Node Excision/methods , Lymph Node Excision/standards , Lymph Node Excision/statistics & numerical data , Neoplasm Staging , Stomach Neoplasms/mortality , Survival Rate , Treatment Outcome
19.
Forensic Sci Int ; 149(1): 35-8, 2005 Apr 20.
Article in English | MEDLINE | ID: mdl-15734107

ABSTRACT

A case of fatal pulmonary embolism with acrylic cement occuring during a percutaneous vertebroplasty on account of a fracture of L1 is described. Autopsy confirmed the presence of large amounts of surgical cement in the paravertebral venous system and in the pulmonary arteries. This rare complication occurred because perivertebral venous cement migration was not recognized during vertebroplasty. To our knowledge, this is the first case of fatal pulmonary embolism caused by surgical cement following a percutaneous vertebroplasty.


Subject(s)
Bone Cements/adverse effects , Extravasation of Diagnostic and Therapeutic Materials/complications , Pulmonary Embolism/etiology , Aged , Aged, 80 and over , Fatal Outcome , Female , Heart Arrest/etiology , Humans , Injections, Spinal/adverse effects , Lumbar Vertebrae/injuries , Lumbar Vertebrae/surgery , Spinal Fractures/surgery
SELECTION OF CITATIONS
SEARCH DETAIL